Understanding MRI: Basic MR physics for physicians

Postgraduate Medical Journal

Volumn 89, Issue 1050, 2013, Pages 209-223

  Currie, Stuart ^a   Hoggard, Nigel ^a   Craven, Ian J ^a   Hadjivassiliou, Marios ^b   Wilkinson, Iain D ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

ECHO PLANAR IMAGING; ELECTROMAGNETIC FIELD; ELECTROMAGNETIC RADIATION; ELECTRON SPIN RESONANCE; IMAGE DISPLAY; MAGNETIC FIELD; MAGNETISM; NEPHROGENIC SYSTEMIC FIBROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR PHYSICS; PROTON; RADIOFREQUENCY; RADIOFREQUENCY RADIATION; RELAXATION TIME; REVIEW; SIGNAL DETECTION; SUPERCONDUCTOR;

GUIDELINES AS TOPIC; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; PHYSICAL PHENOMENA; PHYSICIANS, PRIMARY CARE; PROTONS; REPRODUCIBILITY OF RESULTS;

EID: 84875105924     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2012-131342     Document Type: Review

References (31)

1. Ridgway JP. Cardiovascular magnetic resonance physics for clinicians: part I. J Cardiovasc Magn Reson 2010;12:71.
2. Jacobs MA, Ibrahim TS, Ouwerkerk R. AAPM/RSNA physics tutorials for residents: MR imaging: brief overview and emerging applications. Radiographics 2007;27:1213-29.
3. Hahn EL. Spin Echoes. Phys Rev 1950;80:580-94.
4. Elster A. Questions and answers in magnetic resonance imaging. St Louis: Mosby-Year Book, 1994.
5. Schild H. MRI made easy. Berlin: Schering, 1990.
6. Smith H, Ranello F. A non-mathematical approach to basic MRI. Madison, Wis: Medical Physics Publishing, 1989.
7. Bloch F. Nuclear induction. Phys Rev 1946;70:460.
8. Fullerton G. Physiologic basis of magnetic relaxation. In: Stark D, Bradley W, eds. Magnetic resonance imaging. 2nd edn. St Louis: Mosby-Year Book, 1992: 88-108.
9. Pikus L, Woo JH, Wolf RL, et al. Artificial multiple sclerosis lesions on simulated FLAIR brain MR images: echo time and observer performance in detection. Radiology 2006;239:238-45.
10. Winkler ML, Ortendahl DA, Mills TC, et al. Characteristics of partial flip angle and gradient reversal MR imaging. Radiology 1988;166(1 Pt 1):17-26.
11. Mugler JP III, Brookeman JR. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). Magn Reson Med 1990;15:152-7.
12. Chavhan GB, Babyn PS, Thomas B, et al. Principles, techniques, and applications of T2*-based MR imaging and its special applications. Radiographics 2009;29:1433-49.
13. Thamburaj K, Radhakrishnan VV, Thomas B, et al. Intratumoral microhemorrhages on T2*-weighted gradient-echo imaging helps differentiate vestibular schwannoma from meningioma. AJNR Am J Neuroradiol 2008;29:552-7.
14. Bley TA, Wieben O, Francois CJ, et al. Fat and water magnetic resonance imaging. J Magn Reson Imaging 2010;31:4-18.
15. Ivancevic MK, Geerts L, Weadock WJ, et al. Technical principles of MR angiography methods. Magn Reson Imaging Clin N Am 2009;17:1-11.
16. Morelli JN, Runge VM, Ai F, et al. An image-based approach to understanding the physics of MR artifacts. Radiographics 2011;31:849-66.
17. Jung W, Zvereva V, Hajredini B, et al. Initial experience with magnetic resonance imaging-safe pacemakers: a review. J Interv Card Electrophysiol 2011;32:213-19.
18. Pamboucas C, Nihoyannopoulos P. Cardiovascular magnetic resonance at 3 Tesla: advantages, limitations and clinical potential. Hellenic J Cardiol 2006;47:170-73.
19. Coskun O. Magnetic resonance imaging and safety aspects. Toxicol Ind Health 2011;27:307-13.
20. Chakeres DW, de Vocht F. Static magnetic field effects on human subjects related to magnetic resonance imaging systems. Prog Biophys Mol Biol 2005;87:255-65.
21. Pamboucas CA, Rokas SG. Clinical safety of cardiovascular magnetic resonance: cardiovascular devices and contrast agents. Hellenic J Cardiol 2008;49:352-6.
22. Baikoussis NG, Apostolakis E, Papakonstantinou NA, et al. Safety of magnetic resonance imaging in patients with implanted cardiac prostheses and metallic cardiovascular electronic devices. Ann Thorac Surg 2011;91:2006-11.
23. Li A, Wong CS, Wong MK, et al. Acute adverse reactions to magnetic resonance contrast media-gadolinium chelates. Br J Radiol 2006;79:368-71.
24. Cowper SE, Robin HS, Steinberg SM, et al. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000;356:1000-1.
25. Gauden AJ, Phal PM, Drummond KJ. MRI safety: nephrogenic systemic fibrosis and other risks. J Clin Neurosci 2010;17:1097-104.
26. Gibson SE, Farver CF, Prayson RA. Multiorgan involvement in nephrogenic fibrosing dermopathy: an autopsy case and review of the literature. Arch Pathol Lab Med 2006;130:209-12.
27. Mendoza FA, Artlett CM, Sandorfi N, et al. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 2006;35:238-49.
28. Murphy KJ, Brunberg JA, Cohan RH. Adverse reactions to gadolinium contrast media: a review of 36 cases. AJR Am J Roentgenol 1996;167:847-9.
29. Caro JJ, Trindade E, McGregor M. The cost-effectiveness of replacing high-osmolality with low-osmolality contrast media. AJR Am J Roentgenol 1992;159:869-74.
30. Shellock F, Kanal E. Bioeffects and safety of MR procedures. In: Edelman R, Hesselink J, Zlatkin M, eds. Clinical magnetic resonance imaging. Philadelphia: W.B. Saunders, 1996: 429.
31. Webb JA, Thomsen HS, Morcos SK. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 2005;15:1234-40.